ClinConnect ClinConnect Logo
Search / Trial NCT06447818

Changes in Difficult Airway Markers After Surgery for Obstructive Sleep Apnoea Syndrome

Launched by KOCAELI CITY HOSPITAL · Jun 3, 2024

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Obstructive Sleep Apnea Surgery, Difficult Airway Markers

ClinConnect Summary

This clinical trial is studying how surgery for obstructive sleep apnea (OSA) affects certain markers that indicate difficulties with airway management, which is important for safe anesthesia during surgery. The researchers want to see how these markers change six months after the surgery. This is important because understanding these changes can help improve care for patients who have OSA and may require surgery in the future.

To be eligible for the trial, participants need to be between 18 and 65 years old and classified as having a low to moderate risk for surgery (based on a scale called the ASA score). They should also be scheduled to undergo surgery specifically for obstructive sleep apnea. Participants will be asked to provide both verbal and written consent to join the study. Those who cannot give consent will not be included. If you decide to participate, you can expect to have your airway markers assessed before and after the surgery, helping to contribute to valuable research in this area.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 18-65
  • American society of assosication score (ASA) :1-3
  • To undergo Obstructive sleep apnea surgery (OSAS)
  • Exclusion Criteria:
  • Verbal and written consent cannot be obtained

About Kocaeli City Hospital

Kocaeli City Hospital is a leading healthcare institution located in Kocaeli, Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a sponsor, the hospital leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous and ethically sound clinical studies across various therapeutic areas. Committed to fostering collaboration with healthcare professionals and research organizations, Kocaeli City Hospital aims to contribute to the global medical community by facilitating the development of new treatments and enhancing the standard of care for patients.

Locations

Kocaeli, Izmıt, Turkey

Kocaeli, , Turkey

Patients applied

0 patients applied

Trial Officials

Ayse Sencan, MD

Principal Investigator

Kocaeli City Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported